Competitive Pressures Tough government and academic markets and, toward year end, slowing industrial markets, plus lagging global growth, made 2012 a year when instrument and lab product companies had to compete harder than usual in many markets. Many companies noted pricing pressure across product lines, particularly for sales to industrial markets. This effect also played […]
Global R&D spending is forecast to increase 1.8% to $1,496.4 billion in 2013, measured in purchase powered parity, down from 5.2% growth. R&D expenditures in the life sciences, chemicals and energy sectors are expected to increase 4.2%, 0.6% and 1.6% to account for 13%, 3% and 1% of worldwide R&D spending, respectively. R&D spending is […]
According to the latest EU R&D Scoreboard, produced by the EU’s Joint Research Centre, R&D spending by 1,500 of the world’s largest companies grew 7.6% to €510.7 billion ($709.3 billion = €0.72 = $1) in fiscal 2011 (FY11) (results included FY12 information for some companies). In FY10, Scoreboard companies showed a 4.0% increase in R&D […]
Radnor, PA 12/4/12—VWR International has acquired France-based Labonord and Belgium-based Switch for undisclosed amounts. Labonord supplies consumables and chemicals, including histology products. Switch manufactures cytology and histology reagents and dyes under the Q-Path brand, which are sold in France, Belgium and the Netherlands. Labonord is a Switch distributor.
Even excluding American Recovery and Reinvestment Act (ARRA) funding, US university spending on R&D continued to grow in fiscal year 2011 (FY11) (ending June 30, 2011). Without ARRA funding, university spending on R&D would have grown 4.0% to $60.9 billion, according to the NSF’s Higher Education Research and Development (HERD) Survey. Including ARRA funds, university […]
Waltham, MA and Shanghai, China 11/13/12—PerkinElmer has acquired China-based Shanghai Haoyuan Biotech, an infectious disease diagnostics company, for $38 million in cash and potential future additional consideration. The company supplies molecular infectious disease screening technologies for blood banks and clinical labs in China. The acquisition extends PerkinElmer’s capabilities into nucleic acid blood screening and molecular […]
A trend among major analytical instrument and lab product companies is the expansion into clinical diagnostic markets, both regulated products and, in the US, services based on laboratory developed tests (LDTs). Clinical diagnostics is a fast-growing market, with multiple opportunities due to the use of new research technologies for diagnostics, growth in emerging markets and […]
The European Commission’s “2012 EU Survey on R&D Investment Business Trends” finds that responding companies plan to raise their R&D investments by 4.2% on average from 2012 to 2014. This compares to a projected average increase of 5% in the 2011 survey (see IBO 8/15/11) and, prior to the recession, 7% in the 2007 survey. […]
The world’s 11th largest economy, South Korea is forecast to grow 3.3% this year, according to the country’s Finance Ministry. The economy is expected to grow 4.3% in 2013. The domestic market, which the World Economic Forum defines as GDP plus the value of imports, is currently ranked 12th in size among 142 countries, while […]
At its press conference announcing its purchase of Navigenics (see page 2), Life Technologies provided details of its plan to grow its diagnostics business. Ronnie Andrews, president of Medical Sciences, cited the company’s qPCR, FISH probes and antibody products as among the product lines that will contribute to its diagnostic offerings. As an example of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
